The results suggest that the genetic architecture of PAH, beyond mutations in BMPR2, is characterised by substantial genetic heterogeneity and consists of rare heterozygous coding region mutations shared by small numbers of cases. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.